RxDoctor Payments Data

Harry McNeel

Internal Medicine · St Petersburg, FLNPI 1295720928

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.

$2,317in general payments, 2019–2025

Across 160 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$452
  • Novo Nordisk$293
  • GSK$209
  • Boehringer Ingelheim$178
  • Johnson & Johnson$170
  • Pfizer$143
  • plus $873 from 16 others

What the payments were for

  • Food & beverage$2,29099%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,317 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in St Petersburg

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →